Transcranial sonography findings in Parkinson's disease

Brain and Nerve

Volumn 64, Issue 4, 2012, Pages 413-422

  Izawa, Masae ^a   Miwa, Hideto ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Biomarker; Differential diagnosis; Parkinson's disease; Substantia nigra; Transcranial sonography

Indexed keywords

ARTICLE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; HUMAN; NEUROIMAGING; PARKINSON DISEASE; RADIODIAGNOSIS; TRANSCRANIAL SONOGRAPHY;

DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; PARKINSON DISEASE; SUBSTANTIA NIGRA;

EID: 84859784117     PISSN: 18816096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (78)

1. Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K: Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography. Neurology 45: 182-184, 1995
2. Berg D, Becker G, Zeiler B, Tucha O, Hofmann E, et al: Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 53: 1026-1031, 1999 (Pubitemid 29442119)
3. Berg D, Siefker C, Ruprecht-Dörfler P, Becker G: Relationship of substantia nigra echogenicity and motor function in elderly subjects. Neurology 56: 13-17, 2001 (Pubitemid 32059645)
4. Walter U, Wittstock M, Benecke R, Dressler D: Substantia nigra echogenicity is normal in nonextrapyramidal cerebral disorders but increased in Parkinson's disease. J Neural Transm 109: 191-196, 2002 (Pubitemid 34185665)
5. Godau J, Berg D: Role of transcranial ultrasound in the diagnosis of movement disorders. Neuroimaging Clin N Am 20: 87-101, 2010
6. Seidel G, Kaps M, Gerrirts T, Hutzelmann A: Evaluation of the ventricular system in adults by transcranial duplex sonography. J Neuroimaging 5: 105-108, 1995
7. Spiegel J, Hellwig D, Möllers MO, Behnke S, Jost W, et al: Transcranial sonography and [123I] FP-CIT SPECT disclose complementary aspects of Parkinson's disease. Brain 129: 1188-1193, 2006
8. Walter U: Transcranial brain sonography findings in Parkinson's disease implications for pathogenesis, early diagnosis and therapy. Expert Rev Neurother 9: 835-846, 2009
9. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, et al: Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24: 197-211, 2003 (Pubitemid 36007810)
10. Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, et al: Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114: 1953-1975, 1991
11. Berg D, Gerlach M, Youdim MB, Double KL, Zecca L, et al: Brain iron pathways and their relevance to Parkinson's disease. J Neurochem 79: 225-236, 2001 (Pubitemid 32988938)
12. Berg D, Grote C, Rausch WD, Mäurer M, Wesemann W, et al: Iron accumulation in the substantia nigra in rats visualized by ultrasound. Ultrasound Med Biol 25: 901-904, 1999 (Pubitemid 29325763)
13. Berg D, Roggendorf W, Schröder U, Klein R, Tatschner T, at al: Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 59: 999-1005, 2002 (Pubitemid 34640761)
14. Galazka-Friedman, Friedman A: Controversies about iron in parkinsonian and control substantia nigra. Acta Neurobiol 57: 217-225, 1997
15. Connor JR, Snyder BS, Arosio P, Loeffler DA, LeWitt P: A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains. J Neurochem 65: 717-724, 1995
16. Zecca L, Berg D, Arzberger T, Ruprecht P, Rausch WD, et al: In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage. Mov Disord 20; 1278-1285, 2005 (Pubitemid 41645902)
17. Berg D, Godau J, Riederer P, Gerlach M, Arzberger T: Microglia activation is related to substantia nigra echogenicity. J Neural Transm 117: 1287-1292, 2010
18. Hochstrasser H, Bauer P, Walter U, Behnke S, Spiegel J, et al: Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson's disease. Neurology 63: 1912-1917, 2004 (Pubitemid 39532390)
19. Qian ZM, Ke Y: Rethinking the role of ceruloplasmin in brain iron metabolism. Brain Res Brain Res Rev 35: 287-294, 2001 (Pubitemid 32566201)
20. Kohno S, Miyajima H, Takahashi Y, Inoue Y: Aceruloplasminemia with a novel mutation associated with parkinsonism. Neurogenetics 2: 237-238, 2000 (Pubitemid 30196004)
21. Marder K, Tang MX, Mejia H, Alfaro B, Côté L, et al: Risk of Parkinson's disease among first-degree relatives: A community-based study. Neurology 47: 155-160, 1996 (Pubitemid 26243877)
22. Semchuk KM, Love EJ, Lee RG: Parkinson's disease: a test of the multifactorial etiologic hypothesis. Neurology 43: 1173-1180, 1993 (Pubitemid 23177719)
23. Feamley JM, Lees AJ: Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114: 2283-2301, 1991
24. Piccini P, Burn DJ, Ceravolo R, Maraganore D, Brooks DJ: The role of inheritance in sporadic Parkinson's disease: evidence from longitudinal study of dopaminergic function in twins. Ann Neurol 45: 577-582, 1999 (Pubitemid 29217585)
25. Ruprecht-Dorf ler P, Berg D, Tucha O, Bentz P, Meier-Meitinger M, et al: Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease. Neuroimage 18: 416-422, 2003
26. Hagenah JM, König IR, Becker B, Hilker R, Kasten M, et al: Substantia nigra hyperechogenicity correlates with clinical status and number of Parkin mutated alleles. J Neurol 254: 1407-1413, 2007 (Pubitemid 350112333)
27. Walter U, Klein C, Hilker R, Benecke R, Pramstaller PP, et al: Brain parenchyma sonography detects preclinical parkinsonism. Mov Disord 19: 1445-1449, 2004 (Pubitemid 40104051)
28. Schweitzer KJ, Brussel T, Leitner P, Krüger R, Bauer P, et al: Transcranial ultrasound in different monogenic subtypes of Parkinson's disease. J Neurol 254: 613-616, 2007 (Pubitemid 46781971)
29. Hagenah JM, Becker B, Brüggemann N, Djarmati A, Lohmann K, et al: Transcranial sonography findings in a large family with homozygous and heterozygous PINK1 mutations. J Neurol Neurosurg Psychiatry 79: 1071-1074, 2008
30. Behnke S, Double KL, Duma S, Broe GA, Guenther V, et al: Substantia nigra echomorphology in the healthy very old: Correlation with motor slowing. Neuroimage 34: 1054-1059, 2007 (Pubitemid 46075195)
31. Weidang Le, Shen Chen, Jankovic J: Etiopathogenesis of Parkinson disease: a new beginning? Neuroscientist 15: 28-35, 2009
32. Okawa M, Miwa H, Kajimoto Y, Hama K, Morita S, et al: Transcranial sonography of substantia nigra in Japanese patients with Parkinson's disease or atypical parkinsonism: clinical potential and limitations. Inter Med 46: 1527-1531, 2007 (Pubitemid 47521048)
33. Huang YW, Jeng JS, Tsai CF, Chen LL, Wu RM: Transcranial imaging of sunstantia nigra hyperechogenicity in a Taiwaniese cohort of Parkinson's disease. Mov Disord 22: 550-555, 2007
34. Tsai CF, Wu RM, Huang YW, Chen LL, Yip PK, et al: Transcranial color-coded sonography helps differentiation between idiopathic Parkinson's disease and vascular parkinsonism. J Neurol 254: 501-507, 2007
35. Godau J, Schweitzer KJ, Liepelt I, Gerloff C, Berg D: Substantia nigra hyperechogenicity: Definition and findings in restless legs syndrome. Mov Disord 22: 187-192, 2007 (Pubitemid 46374759)
36. Gaenslen A, Unmuth B, Godau J, Liepelt I, Di Santo A, et al: The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study. Lancet Neurol 7: 417-424, 2008
37. Kim JY, Kim ST, Jeon SH, Lee WY: Midbrain transcranial sonography in Korean patients with Parkinson's disease. Mov Disord 22: 1922-1926, 2007
38. Walter U, Behnke S, Eyding J, Niehaus L, Postert T, et al: Transcranial brain parenchyma sonography in movement disorders: state of the art. Ultrasound Med Biol 33: 15-25, 2007 (Pubitemid 44959319)
39. Halsey JH: Effect of emitted power on waveform intensity in transcranial doppler. Stroke 21: 1573-1578, 1990
40. Resch H, Pietschmann P, Bernecker P, Krexner E, Willvonseder R: Broadband ultrasound attenuation: A new diagnostic method in osteoporosis. AJR Am J Roentgenol 155: 825-828, 1990 (Pubitemid 20305047)
41. Evans JA, Tavakoli MB: Ultrasonic attenuation and velocity in bone. Phys Med Biol 35: 1387-1396, 1990 (Pubitemid 20304107)
42. Walter U, Hoeppner J, Prudente-Morrissey L, Horowski S, Herpertz SC, et al: Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders. Brain 130: 1799-1807, 2007 (Pubitemid 47343787)
43. Skoloudìk D, Fadrná T, Bártová P, Langová K, Ressner P, et al: Reproducibility of sonographic measurement of the substantia nigra. Ultrasound Med Biol 33: 1347-1352, 2007 (Pubitemid 47302201)
44. Behnke S, Berg D, Naumann M, Becker G: Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound. J Neurol Neurosurg Psychiatry 76: 423-425, 2005 (Pubitemid 40299138)
45. Walter U, Niehaus L, Probst T, Benecke R, Meyer BU, et al: Brain parenchyma sonogaphy discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology 60: 74-77, 2003 (Pubitemid 36070647)
46. Walter U, Dressier D, Probst T, Wolters A, Abu-Mugheisib M, et al: Transcranial brain sonography findings in discriminating between Parkinsonism and idiopathic Parkinson disease. Arch Neurol 64: 1635-1640, 2007 (Pubitemid 350106766)
47. Ebentheuer J, Canelo M, Trautmann E, Trenkwalder C: Substantia nigra echogenicity in progressive supranuclear palsy. Mov Disord 25: 765-876, 2010
48. Walter U, Dressier D, Wolters A, Probst T, Grossmann A, et al: Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy. Neurology 63: 504-509, 2004 (Pubitemid 39031381)
49. Walter U, Dressier D, Wolters A, Wittstock M, Greim B, et al: Sonographic discrimination of dementia with Lewy bodies and Parkinson's disease with dementia. J Neurol 253: 448-454, 2006 (Pubitemid 43965609)
50. Stockner H, Sojer M, K KS, Mueller J, Wenning GK, et al: Midbrain sonography in patients with essential tremor. Mov Disord 22: 414-417, 2007
51. 123I-FP-CIT SPECT in Parkinson's disease and essential tremor. Mov Disord 23: 405-410, 2008
52. Schuurman AG, van den Akker M, Ensinck KT, Metsemakers JF, Knottnerus JA, et al: Increased risk of Parkinson's disease after depression: a retrospective cohort study. Neurology 58: 1501-1504, 2002 (Pubitemid 34552956)
53. Leentjens AF, Van den Akker M, Metsemakers JF, Lousberg R, Verhey FR: Higher incidence of depression preceding the onset of Parkinson's disease: a register study. Mov Disord 18: 414-418, 2003 (Pubitemid 36527282)
54. Berg D: Marker for a preclinical diagnosis of Parkinson's disease as a basis for neuroprotection. J Neural Transm 71: 123-132, 2006
55. Berg D: Biomarkers for the early detection of Parkinson's and Alzheimer's disease. Neurodegener 5: 133-136, 2008
56. Becker G, Becker T, Struck M, Linder A, Burzer K, et al: Reduced echogenicity of brainstem raphe specific to unipolar depression: a transcranial color-coded real-time sonography study. Biol Psychiatry 38: 180-184, 1995
57. Walter U, Prudente-Morrissey L, Herpertz SC, Benecke R, Hoeppner J, et al: Relationship of brainstem raphe echogenicity and clinical findings in depressive status. Psychiatry Res 155: 67-73, 2007 (Pubitemid 46561250)
58. Becker G, Struck M, Bogdahn U, Becker T: Echogenicity of the brainstem raphe in patients with major depression. Psychiatry Res 55: 75-84, 1994 (Pubitemid 24197575)
59. Walter U, Krolikowski K, Tarnacka B, Benecke R, Czlonkowska A, et al: Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease. Neurology 64: 1726-1732, 2005 (Pubitemid 40695806)
60. Walter U, Dressler D, Lindemann C, Slachevsky A, Miranda M: Transcranial sonography findings in welding-related Parkinsonism in comparison to Parkinson's disease. Mov Disord 23: 141-145, 2008 (Pubitemid 351281235)
61. Naumann M, Becker G, Toyka KV, Supprian T, Reiners K: Lenticular nucleus lesion in idiopathic dystonia detected by transcranial sonography. Neurology 47: 1284-1290, 1996 (Pubitemid 26374901)
62. Berg D, Merz B, Reiners K, Naumann M, Becker G: Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease. Mov Disord 20: 383-385, 2005 (Pubitemid 40613305)
63. Berg D: Transcranial ultrasound as a risk marker for Parkinson's disease. Mov Disord 24: S677-S683, 2009
64. Berg D, Siefker C, Becker G: Echogenicity of he substantia nigra in Parkinson's disease and its relation to clinical findings. J Neurol 248: 684-689, 2001 (Pubitemid 32695865)
65. Walter U, Dressier D, Walters A, Wittstock M, Benecke R: Transcranial brain sonography findings in clinical subgroups of idiopathic Parkinson's disease. Mov Disord 22: 48-54, 2007 (Pubitemid 46382672)
66. Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184, 1992
67. Schapira AH: Progress in neuroprotection in Parkinson's disease. Eur J Neurol 12: 5-13, 2008
68. Doty RL, Shaman P, Kimmelman CP, Dann MS: University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic. Laryngoscope 94: 176-178, 1984 (Pubitemid 14186660)
69. Ponsen MM, Stoffers D, Twisk JW, Wolters E, Berendse HW: Hyposmia and executive dysfunction as predictors of future Parkinson's disease: a prospective study. Mov Disord 24: 1060-1065, 2009
70. Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H: (123)I- metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry 67: 189-194, 1999 (Pubitemid 29326950)
71. Kajimoto Y, Miwa H, Izawa OM, Hironishi M, Kondo T: Transcranial sonography of substantia nigra and MIBG myocardial scintigraphy: complementary role in diagnosis of Parkinson's disease. Parkinsonism Relat Disord 15: 270-272, 2009
72. Izawa OM, Miwa H, Kajimoto Y, Kondo T: Combination of transcranial sonography, olfactory testing, and MIBG myocardial scintigraphy as a diagnostic indicator for Parkinson's disease. Eur J Neurol 19: 411-416, 2012
73. Oka H, Toyoda C, Yogo M, Mochio S: Olfactory dysfunction and cardiovascular dysautonomia in Parkinson's disease. J Neurol 257: 969-976, 2010
74. Berg D, Merz B, Reiners K, Naumann M, Becker G: Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease. Mov Disord 20: 383-385, 2005 (Pubitemid 40613305)
75. Berg D, Seppi K, Behnke S, Liepelt I, Schweizer K, et al: Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older persons. Arch Neurol 68; 932-937, 2011